Vimpat is commonly prescribed in combination with other seizure medications for the treatment of certain types of seizures, known as partial seizures. It is available in the form of a tablet that is typically taken twice a day. There is also an injectable form that can be administered intravenously in certain situations. Headaches, dizziness, and nausea are common side effects reported with this medication.
Vimpat® (lacosamide) is a prescription medication approved to treat certain types of seizures (known as partial-onset seizures, partial seizures, or focal seizures) in people 17 years old and older. It is approved for use only in combination with other seizure medications.
(Click Vimpat Uses for more information on what the medication is used for, including possible off-label uses.)
Vimpat is made by UCB, Inc.
Seizures are the result of brief changes in how the brain's electrical system works. It is not known exactly how Vimpat works for treating seizures. Studies suggest that it may work by affecting sodium channels in the brain, preventing the abnormal activity from "firing" and spreading to other parts of the brain. This action helps control seizures.
This medication has been thoroughly evaluated in clinical studies. These studies evaluated Vimpat in people with partial-onset seizures whose seizures were not adequately controlled with their current medications. In one study, adding Vimpat significantly reduced seizure frequency by up to 40 percent, compared to only 10 percent in those people who were given a placebo (a "sugar pill" that does not contain any active ingredients) in addition to their regular seizure medications.